UA71493U - Композиция для очищения организма и нормализации микрофлоры кишечника - Google Patents
Композиция для очищения организма и нормализации микрофлоры кишечника Download PDFInfo
- Publication number
- UA71493U UA71493U UAU201201128U UAU201201128U UA71493U UA 71493 U UA71493 U UA 71493U UA U201201128 U UAU201201128 U UA U201201128U UA U201201128 U UAU201201128 U UA U201201128U UA 71493 U UA71493 U UA 71493U
- Authority
- UA
- Ukraine
- Prior art keywords
- lignin
- lactulose
- microcrystalline cellulose
- normalization
- dietary
- Prior art date
Links
- 235000005911 diet Nutrition 0.000 title claims abstract 4
- 238000010606 normalization Methods 0.000 title abstract description 5
- 239000013589 supplement Substances 0.000 title abstract description 3
- 230000000378 dietary effect Effects 0.000 title abstract 3
- 244000005706 microflora Species 0.000 title description 7
- 230000002496 gastric effect Effects 0.000 title 1
- 229920005610 lignin Polymers 0.000 claims abstract description 18
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 16
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 16
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims abstract description 15
- 229960000511 lactulose Drugs 0.000 claims abstract description 15
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 15
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 239000000835 fiber Substances 0.000 claims abstract description 6
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims abstract description 5
- 235000013539 calcium stearate Nutrition 0.000 claims abstract description 5
- 239000008116 calcium stearate Substances 0.000 claims abstract description 5
- 239000000454 talc Substances 0.000 claims abstract 2
- 229910052623 talc Inorganic materials 0.000 claims abstract 2
- 235000013325 dietary fiber Nutrition 0.000 claims description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 6
- 229910002012 Aerosil® Inorganic materials 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000015872 dietary supplement Nutrition 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- 230000037213 diet Effects 0.000 claims 1
- 235000020931 dietary conditions Nutrition 0.000 claims 1
- 230000007659 motor function Effects 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract description 2
- 239000000443 aerosol Substances 0.000 abstract 1
- 230000005176 gastrointestinal motility Effects 0.000 abstract 1
- 235000012222 talc Nutrition 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- -1 radioactive isotopes Inorganic materials 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 108700012359 toxins Proteins 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000001072 colon Anatomy 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000002893 slag Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000014644 Brain disease Diseases 0.000 description 2
- 208000032274 Encephalopathy Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 150000001243 acetic acids Chemical class 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 150000004674 formic acids Chemical class 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000000055 hyoplipidemic effect Effects 0.000 description 2
- 230000003240 hypoazotemic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000002676 xenobiotic agent Substances 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000009492 tablet coating Methods 0.000 description 1
- 239000002700 tablet coating Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Диетическая добавка к рациону питания является дополнительным источником пищевых волокон для создания оптимальных диетологических условий для нормализации моторной функции желудочно-кишечного тракта. Содержит лигнин гидролизный, лактулозу, вспомогательные вещества: аэросил, кальция стеарат, тальк и целлюлозу микрокристаллическую.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201201128U UA71493U (ru) | 2012-02-03 | 2012-02-03 | Композиция для очищения организма и нормализации микрофлоры кишечника |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201201128U UA71493U (ru) | 2012-02-03 | 2012-02-03 | Композиция для очищения организма и нормализации микрофлоры кишечника |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA71493U true UA71493U (ru) | 2012-07-10 |
Family
ID=50848526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201201128U UA71493U (ru) | 2012-02-03 | 2012-02-03 | Композиция для очищения организма и нормализации микрофлоры кишечника |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA71493U (ru) |
-
2012
- 2012-02-03 UA UAU201201128U patent/UA71493U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8759398B2 (en) | Phosphorus binder composition for treatment of hyperphosphatemia | |
| ES2542879T3 (es) | Composición farmacéutica para prevenir la disbiosis asociada con la administración enteral de antibióticos | |
| JP5739659B2 (ja) | 腸内有害物質吸着剤及びその製造方法 | |
| EP2598123A1 (en) | Compositions | |
| JP2009519897A5 (ru) | ||
| CN110507620A (zh) | 一种复方硫酸氨基葡萄糖分散片及其制备方法 | |
| CN102844077A (zh) | 一种用于中和胃酸的固体药物组合物 | |
| UA71493U (ru) | Композиция для очищения организма и нормализации микрофлоры кишечника | |
| CN107441117A (zh) | 一种多维元素钙制剂及其制备方法 | |
| JP4373634B2 (ja) | 一酸化窒素消去剤 | |
| CN101756949A (zh) | 一种盐酸氨溴索与半胱氨酸的组合物及其制备方法 | |
| CN117440799A (zh) | 包含活性炭和壳聚糖的固体形式的制剂、制备所述制剂的方法、包含所述制剂的组合物以及所述组合物的用途 | |
| JP3884611B2 (ja) | 衝動性疾患の改善剤 | |
| RU2325187C1 (ru) | Фармацевтическая композиция антибиотиков и пребиотиков (варианты) для профилактики и лечения дисбиозов в процессе антибактериальной терапии | |
| RU2297234C2 (ru) | Средство "фуколамин" для профилактики и лечения заболеваний желудочно-кишечного тракта, сердечно-сосудистой и эндокринной систем | |
| RU2777203C1 (ru) | Способ выведения из организма солей тяжелых металлов | |
| CN105726491A (zh) | 治疗肠胃疾病的聚六亚甲基胍药物及其制备方法和应用 | |
| RU2325166C1 (ru) | Фармацевтическая композиция антибиотиков и лактулозы для профилактики энтеральных дисбиозов в процессе антибиотикотерапии | |
| CN105687225B (zh) | 一种治疗肠易激综合征的药物组合物及其制备方法和应用 | |
| RU2279278C2 (ru) | Энтеросорбент | |
| JP7505831B2 (ja) | 海藻抽出物を含む高血圧症改善剤並びに同高血圧症改善剤を含む機能性食品、医薬部外品及び医薬品 | |
| RU2540466C2 (ru) | Антиоксидантное и мембраностабилизирующее средство | |
| Tong et al. | Iron poisoning | |
| JPH05213762A (ja) | リン吸着剤 | |
| Currie et al. | A Randomized, Blinded, Calcium-Carbonate Controlled Cross over Study of Serum Calcium Levels 24 Hours after CalGotm Oral Supplementation in Post-Menopausal Women |